Steven Cohen Biomarin Pharmaceutical Inc Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 197,718 shares of BMRN stock, worth $12.5 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

197,718

Holding current value

$12.5 Million

% of portfolio

0.04%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $13.6 Million - $18.6 Million	197,718 New	197,718 $13.9 Million
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $74.6 Million - $88.2 Million	890,420 Added 195.57%	1,345,720 $118 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $34.7 Million - $44.9 Million	455,300 New	455,300 $43.9 Million
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $62.9 Million - $84 Million	-716,700 Closed	0 $0
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $9.82 Million - $13.2 Million	121,300 Added 20.37%	716,700 $74.2 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $36.8 Million - $43.4 Million	447,529 Added 302.65%	595,400 $50.5 Million
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $15.7 Million - $19 Million	-218,965 Reduced 59.69%	147,871 $12.3 Million
Q1 2022 May 16, 2022	SELL	$74.28 - $92.69 $33.8 Million - $42.2 Million	-454,960 Reduced 55.36%	366,836 $28.3 Million
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $2.15 Million - $2.74 Million	30,007 Added 3.79%	821,796 $72.6 Million
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $31.8 Million - $36.3 Million	425,289 Added 116.04%	791,789 $61.2 Million
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $8.31 Million - $9.33 Million	110,000 Added 42.88%	366,500 $30.6 Million
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $9.31 Million - $11.3 Million	-124,600 Reduced 32.69%	256,500 $19.4 Million
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $40.8 Million - $50.7 Million	-562,593 Reduced 59.62%	381,100 $33.4 Million
Q3 2020 Nov 16, 2020	BUY	$71.87 - $131.03 $67.8 Million - $124 Million	943,693 New	943,693 $71.8 Million
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $18.6 Million - $25.2 Million	-260,683 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $12.6 Million - $16.9 Million	196,010 Added 303.08%	260,683 $22 Million
Q3 2019 Nov 15, 2019	SELL	$67.4 - $85.11 $12.6 Million - $15.9 Million	-186,973 Reduced 74.3%	64,673 $4.36 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $20.2 Million - $23.6 Million	251,646 New	251,646 $21.6 Million
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $5.04 Million - $5.68 Million	-53,703 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$76.01 - $99.03 $15.1 Million - $19.6 Million	-198,397 Reduced 78.7%	53,703 $5.06 Million
Q1 2018 May 15, 2018	SELL	$77.67 - $92.63 $19 Million - $22.7 Million	-245,249 Reduced 49.31%	252,100 $20.4 Million
Q4 2017 Feb 14, 2018	SELL	$80.76 - $95.13 $22 Million - $25.9 Million	-272,193 Reduced 35.37%	497,349 $44.3 Million
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $62 Million - $73.1 Million	769,542	769,542 $71.6 Million

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account